Gerresheimer stock holds firm ahead of AGM and Q1 update
Published on 08/31/2026 at 16:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gerresheimer AG stock (DE000A0LD6E6) was last quoted at EUR 26.50 on August 28, 2026, as investors positioned for the company's virtual annual general meeting on September 1, 2026. The most recent first-quarter 2026 update showed EUR 524 million in revenue and EUR 66 million in adjusted EBITDA, with free cash flow at minus EUR 32 million.
Q1 numbers set the tone
The first-quarter figures point to a mixed operating picture. Revenue rose 1 percent from EUR 519 million a year earlier, while adjusted EBITDA fell from EUR 81 million to EUR 66 million and the margin slipped to 12.6 percent from 15.7 percent.
Free cash flow improved by EUR 109 million year over year, moving from minus EUR 141 million in Q1 2025 to minus EUR 32 million in Q1 2026. That kind of improvement matters because it shows cash generation is recovering even as profitability remains under pressure.
Trading stays anchored
The share price reference of EUR 26.50 on August 28, 2026 gives the stock a clear level to watch against the Q1 operating trend. On the same tradegate session, the shares were up 0.15 percent, which signals a calm reaction into the AGM window.
Special Situations Digest listed Gerresheimer at EUR 26.62 with a market cap of $1.1 billion and forward EV/EBITDA of 7.4x, a valuation backdrop that leaves little room for major disappointment. For investors, the market is still pricing the stock on execution rather than on a simple revenue story.
Packaging still matters
Gerresheimer's core business remains pharmaceutical packaging, including drug containment solutions for healthcare and life sciences customers. That makes the cash-flow trend and margin path more relevant than a single quarter's revenue line.
Stock level to watch
As of August 28, 2026, Gerresheimer stock traded at EUR 26.50 on Tradegate. The level sits close to the EUR 26.62 reference used in recent market coverage and keeps the focus on whether the company can protect margins while improving cash flow.
Fact box
Company: Gerresheimer AG
ISIN: DE000A0LD6E6
Ticker: GXI
Exchange: Tradegate
Price (as of August 28, 2026, 10:25 p.m. ET): EUR 26.50
Market cap: $1.1 billion (as of August 30, 2026)
Sector / Industry: Healthcare / Pharmaceutical packaging
Index membership: SDAX
